
Conversis Medical hires global director
pharmafile | June 23, 2014 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | conversis, hooper, medical
Medical translation agency Conversis Medical has appointed Dr Mark Hooper as its global director.
Hooper has worked in the pharma services field for the past 13 years and takes to Conversis business development and project delivery experience from this sector, but also CRO/CMO market knowledge.
Conversis Medical founder Gary Muddyman says: “This is a significant appointment and we are delighted that Mark has joined us. Conversis Medical is committed to meeting the demand for precise translation for patient recruitment and within the clinical trials sector and Mark has a fantastic track record in delivering outstanding client service and satisfaction – values which are embedded in the ethos of the company.”
Hooper adds: “I am delighted to be joining such a forward-thinking translation company as Conversis Medical, which values understanding the specific needs of the pharmaceutical industry.”
Related Content

LabCorp buys Covance for $6.1 billion
US medical diagnostics firm LabCorp has entered the drug development business via a $6.1 billion …
Havas Lynx launches med ed agency
The healthcare communications group Havas Lynx has created a new medical education and scientific exchange …
The medical-marketing interface and how to bridge the gap
Drug companies are not charities and are accountable to their shareholders, as we all know. …






